Health

The study conducted by Inger Jorid Berg, MD, PhD, and colleagues at Diakonhjemmet Hospital in Oslo, Norway, aimed to evaluate different approaches to follow-up care for patients with axial spondyloarthritis (axSpA). The study compared traditional in-person follow-up visits with remote monitoring and patient-initiated care. The findings of the study were presented at the European Alliance
0 Comments
As we delve into the realm of environmental concerns, one looming threat stands out – air pollution. Recent studies have unraveled a concerning link between maternal exposure to particulate matter (PM) and adverse pregnancy outcomes, particularly related to blood pressure complications. This revelation sheds light on the urgency of addressing this hidden risk to maternal
0 Comments
Dr. Erminia Massarelli, from the City of Hope in Duarte, California, recently discussed the findings of a phase II study on utilizing osimertinib (Tagrisso) in combination with consolidative stereotactic ablative radiation (SABR) for the treatment of advanced EGFR-mutant non-small cell lung cancer (NSCLC). This study was presented at the American Society of Clinical Oncology (ASCO)
0 Comments
The FDA advisory committee unanimously supported the investigational drug donanemab for treating early Alzheimer’s disease in a recent 11-0 vote. The committee highlighted that the benefits of donanemab outweighed its risks for Alzheimer’s disease patients with mild cognitive impairment and mild dementia who were enrolled in clinical trials involving the drug. In addition to the
0 Comments
In the realm of healthcare, various challenges and complexities arise, requiring constant evaluation and examination. Rep. Jamie Raskin’s statement regarding Anthony Fauci sheds light on the House subcommittee investigation into COVID-19’s origins, emphasizing the need for transparency and accountability in addressing public health crises. Jason Liebowitz’s experience at a physician-owned practice being acquired by a
0 Comments
The SYNERGY-NASH phase II study has brought forth encouraging news in the realm of treating Metabolic Dysfunction-Associated Steatohepatitis (MASH) and liver fibrosis. The trial, led by Dr. Rohit Loomba, showcased promising results with the use of tirzepatide, a novel weight loss and diabetes drug. With biopsy-confirmed MASH and fibrosis in 190 participants, the study revealed
0 Comments
The news of Dr. Michael Mosley, a renowned British weight-loss doctor and television personality, going missing while on vacation in Greece has raised alarm bells. Authorities in Greece are working tirelessly to locate him, sparking worry and speculation about the circumstances surrounding his disappearance. Conservative groups affiliated with former President Donald Trump are making efforts
0 Comments